This site is intended for healthcare professionals
Small cell lung cancer, light micrograph
Video series: Transforming SCLC care

Video: First-line care in ES-SCLC

Supported by Amgen
Last updated: 7th Nov 2026
Published: 7th Nov 2026

Applying first-line and maintenance treatment strategies in ES-SCLC

Gain insights into first-line treatment strategies for extensive-stage small-cell lung cancer (ES-SCLC) with Jacob Sands (Harvard Medical School, Boston, Massachusetts, USA) and Solange Peters (Lausanne University Hospital [CHUV], Switzerland). In this accredited video, they discuss first-line chemoimmunotherapy, maintenance treatment strategies, emerging evidence, and how evolving data may shape clinical practice. Earn up to 20 minutes of effective education time upon successful completion.

How much do you know about first-line and maintenance treatment in ES-SCLC?

Answer this question to find out. We’ll ask it again after you’ve watched the video to see what you recall.

1. Which factor is most important when selecting a guideline-recommended first-line treatment strategy for a patient with ES-SCLC?

Episode 3. Join thoracic oncologists Jacob Sands and Solange Peters as they discuss first-line treatment strategies for ES-SCLC. They explore chemoimmunotherapy, maintenance treatment, emerging clinical evidence, and how evolving data may shape clinical practice. View transcript.

This video is part of an accredited series for oncologists, including thoracic oncologists, involved in the care of people with ES-SCLC.

A total of 1 CME credit is available across all three episodes, with each episode worth up to 20 minutes of effective education time. To claim credit for an episode, complete the associated knowledge quiz and evaluation form after viewing the video. To claim credit for more than one video, complete the full assessment.

Important note: If you are not logged into your Medthority account, please complete the full session without exiting your browser. If you exit before finishing, you’ll need to restart from the beginning. We recommend logging in to preserve your progress if you need to pause. Not a member yet? You can set up your free account in just a few minutes.

Thank you for watching the video. Please answer these final questions to earn your CME credit.

1. Which factor is most important when selecting a guideline-recommended first-line treatment strategy for a patient with ES-SCLC?

2. The activity has been scientifically rigorous and evidence-based
3. I have identified bias
C. If yes, it has been

4. Please rate your level of agreement with the following statements (5 = Strongly agree; 1 = Strongly disagree):

Please complete the fields below to claim your CME credit.

Optional: I confirm that I am happy to receive further information about this video series and relevant Medthority updates by email.

MORE SCLC RESOURCES

Amgen EBAC

Developed independently by EPG Health, which received educational funding from Amgen awarded to EPG Health to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. EPG Health is an EBAC® Accredited Provider since 2026.

This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 01:00 hours of effective education time.

EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the European Board for Accreditation of Continuing Education for Health Professionals, Royal College MOC Section 1 credits are deemed to be substantively equivalent to EBAC CPD credits.

EBAC® is a member of the International Academy for CPD Accreditation (IACPDA), the World Federation for Medical Education (WFME) CPD Recognition Committee, and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).